TORONTO, Oct. 31,
2022 /CNW/ - Pathway Health Corp. (TSXV: PHC)
(Frankfurt: KL1) (formerly Colson Capital Corp.) ("Pathway" or the
"Company"), an integrated healthcare company that provides products
and services to patients suffering from chronic pain and related
conditions, is pleased to announce that it has signed a
Collaboration Agreement (the "Agreement") with Sunshine Drugs, a
family of 15 community based pharmacies located primarily in
Southwest Ontario. The agreement
details the implementation of Pathway's Medical Cannabis Management
System ("MCMS") in a planned November, 2022 rollout.
The joint initiative has two components, the first consisting of
Pathway providing its accredited continuing education course
"Cannabis and Patient Care for Pharmacists" which trains
pharmacists in patient assessments and current prescription reviews
for patient suitability. The course meets or exceeds the
requirements of the Canadian Council on Continuing Education in
Pharmacy ("CCCEP") and the Ontario
College of Pharmacists as well as being approved for all other
Provinces and in a bi-lingual format. The second initiative
involves the implementation of Pathway's MCMS in various Sunshine
Pharmacy locations in Canada.
Pathway's MCMS was designed to be implemented in retail
pharmacies, with the overarching goals of providing access points
for medical cannabis care and enabling pharmacists to offer medical
cannabis assessments to appropriate pharmacy patients. Under the
MCMS, patients are then connected to their own General Practitioner
or a Pathway physician/nurse practitioner for further evaluation
through either physical or telemedicine care. The MCMS has also
been designed to be integrated into a formal medication review for
the pharmacist. The MCMS offers patient assessment tools for the
pharmacist including consent forms, marketing material, back-end
patient communication, standard operating procedures, and
additional continuing education opportunities to over 2,000
pharmacies across Canada.
"We're pleased to add the Sunshine Drugs group of pharmacies to
the continued increasing roster of Canadian locations involved with
the MCMS program. The Sunshine Drugs Family of Pharmacies is a
leader in the transformation of healthcare services from a
product-focused model to a patient centric approach that customizes
each patient's healthcare plan. As we anticipate changes from
Health Canada to allow for the sale of Cannabis Health Products in
pharmacies, forward thinking chains are staking their position as
the leaders in education, advice and safety for consumers
researching medical cannabis," stated Ken
Yoon, CEO of Pathway Health.
About Pathway Health
Pathway Health is an integrated healthcare company that provides
products and services to patients suffering from chronic pain and
related conditions. The Company owns and operates twelve
community-based clinics across five provinces where its team of
health professionals work together to help patients through a
variety of evidence-based approaches and products, including
medical cannabis. Pathway Health's patient care programs utilize an
interdisciplinary approach that is guided by trained pain
specialists, physical and occupational therapists, psychologists,
nurses, and other healthcare providers. Pathway is also the leading
provider of medical cannabis services in Canada and has established itself as the
leading partner with national and regional pharmacy companies for
the delivery of medical cannabis services to their customers. The
Company is working with several pharmacy companies on the
development of Cannabis Health Products (CHPs) for OTC product
distribution through retail pharmacy locations across the country
following anticipated changes to the Cannabis Act.
For more information, visit Pathway Health's website:
www.pathwayhealth.ca
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING
INFORMATION
This news release includes certain "forward-looking
statements" under applicable Canadian securities legislation.
Forward-looking statements are necessarily based upon a number of
estimates and assumptions that, while considered reasonable, are
subject to known and unknown risks, uncertainties, and other
factors that may cause the actual results and future events to
differ materially from those expressed or implied by such
forward-looking statements. Such factors include, but are not
limited to: general business, economic, competitive, political and
social uncertainties; delay or failure to receive applicable
approvals; and the results of operations. There can be no assurance
that such statements will prove to be accurate, as actual results
and future events could differ materially from those anticipated in
such statements. Accordingly, readers should not place undue
reliance on forward-looking statements. Pathway disclaims any
intention or obligation to update or revise any forward-looking
statements, whether as a result of new information, future events
or otherwise, except as required by law.
Neither the Exchange nor its Regulation Services Provider (as
that term is defined in the policies of the Exchange) accepts
responsibility for the adequacy or accuracy of this Press Release.
The TSX Venture Exchange Inc. has in no way passed upon the merits
of the proposed transaction and has neither approved nor
disapproved the contents of this press release.
SOURCE Pathway Health Corp.